Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

United States Gene Vector Market Report 2016

  • QYR673175
  • 117 Pages
  • September 2016
  • Pharmaceuticals
Download Sample    Get Discount   
 
Notes:

Sales, means the sales volume of Gene Vector

Revenue, means the sales value of Gene Vector

This report studies sales (consumption) of Gene Vector in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering

A.G. Scientific, Inc. (US)

Abbott Diagnostics (US)

Agilent Technologies, Inc. (US)

BD Biosciences (US)

Beckman Coulter, Inc. (US)

bioMerieux (France)

Bio-Rad Laboratories, Inc. (US)

F. Hoffmann-La Roche Ltd. (Switzerland)

Gallus Immunotech, Inc. (Canada)

GE Healthcare (UK)

Lonza Biologics Ltd. (Switzerland)

Merck KGaA (Germany)

Meridian Life Science, Inc. (US)

PerkinElmer, Inc. (US)

Promega Corporation (US)

Qiagen N.V. (Netherlands)

R&D Systems (US)

SDIX, LLC (US)

Shimadzu Corporation (Japan)

Takara Bio, Inc. (Japan)

Thermo Fisher Scientific Inc. (US)

Wako Pure Chemical Industries Ltd. (Japan)

Waters Corp. (US)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

Type I

Type II

Type III

Split by applications, this report focuses on sales, market share and growth rate of Gene Vector in each application, can be divided into

Medical care

Experiment

Application 3

Table of Contents

United States Gene Vector Market Report 2016

1 Gene Vector Overview

1.1 Product Overview and Scope of Gene Vector

1.2 Classification of Gene Vector

1.2.1 Type I

1.2.2 Type II

1.2.3 Type III

1.3 Application of Gene Vector

1.3.1 Medical care

1.3.2 Experiment

1.3.3 Application 3

1.4 USA Market Size Sales (Value) and Revenue (Volume) of Gene Vector (2011-2021)

1.4.1 USA Gene Vector Sales and Growth Rate (2011-2021)

1.4.2 USA Gene Vector Revenue and Growth Rate (2011-2021)

2 USA Gene Vector Competition by Manufacturers

2.1 USA Gene Vector Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 USA Gene Vector Revenue and Share by Manufactures (2015 and 2016)

2.3 USA Gene Vector Average Price by Manufactures (2015 and 2016)

2.4 Gene Vector Market Competitive Situation and Trends

2.4.1 Gene Vector Market Concentration Rate

2.4.2 Gene Vector Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 USA Gene Vector Sales (Volume) and Revenue (Value) by Type (2011-2016)

3.1 USA Gene Vector Sales and Market Share by Type (2011-2016)

3.2 USA Gene Vector Revenue and Market Share by Type (2011-2016)

3.3 USA Gene Vector Price by Type (2011-2016)

3.4 USA Gene Vector Sales Growth Rate by Type (2011-2016)

4 USA Gene Vector Sales (Volume) by Application (2011-2016)

4.1 USA Gene Vector Sales and Market Share by Application (2011-2016)

4.2 USA Gene Vector Sales Growth Rate by Application (2011-2016)

4.3 Market Drivers and Opportunities

5 USA Gene Vector Manufacturers Profiles/Analysis

5.1 A.G. Scientific, Inc. (US)

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Gene Vector Product Type, Application and Specification

5.1.2.1 Type I

5.1.2.2 Type II

5.1.3 A.G. Scientific, Inc. (US) Gene Vector Sales, Revenue, Price and Gross Margin (2011-2016)

5.1.4 Main Business/Business Overview

5.2 Abbott Diagnostics (US)

5.2.2 Gene Vector Product Type, Application and Specification

5.2.2.1 Type I

5.2.2.2 Type II

5.2.3 Abbott Diagnostics (US) Gene Vector Sales, Revenue, Price and Gross Margin (2011-2016)

5.2.4 Main Business/Business Overview

5.3 Agilent Technologies, Inc. (US)

5.3.2 Gene Vector Product Type, Application and Specification

5.3.2.1 Type I

5.3.2.2 Type II

5.3.3 Agilent Technologies, Inc. (US) Gene Vector Sales, Revenue, Price and Gross Margin (2011-2016)

5.3.4 Main Business/Business Overview

5.4 BD Biosciences (US)

5.4.2 Gene Vector Product Type, Application and Specification

5.4.2.1 Type I

5.4.2.2 Type II

5.4.3 BD Biosciences (US) Gene Vector Sales, Revenue, Price and Gross Margin (2011-2016)

5.4.4 Main Business/Business Overview

5.5 Beckman Coulter, Inc. (US)

5.5.2 Gene Vector Product Type, Application and Specification

5.5.2.1 Type I

5.5.2.2 Type II

5.5.3 Beckman Coulter, Inc. (US) Gene Vector Sales, Revenue, Price and Gross Margin (2011-2016)

5.5.4 Main Business/Business Overview

5.6 bioMerieux (France)

5.6.2 Gene Vector Product Type, Application and Specification

5.6.2.1 Type I

5.6.2.2 Type II

5.6.3 bioMerieux (France) Gene Vector Sales, Revenue, Price and Gross Margin (2011-2016)

5.6.4 Main Business/Business Overview

5.7 Bio-Rad Laboratories, Inc. (US)

5.7.2 Gene Vector Product Type, Application and Specification

5.7.2.1 Type I

5.7.2.2 Type II

5.7.3 Bio-Rad Laboratories, Inc. (US) Gene Vector Sales, Revenue, Price and Gross Margin (2011-2016)

5.7.4 Main Business/Business Overview

5.8 F. Hoffmann-La Roche Ltd. (Switzerland)

5.8.2 Gene Vector Product Type, Application and Specification

5.8.2.1 Type I

5.8.2.2 Type II

5.8.3 F. Hoffmann-La Roche Ltd. (Switzerland) Gene Vector Sales, Revenue, Price and Gross Margin (2011-2016)

5.8.4 Main Business/Business Overview

5.9 Gallus Immunotech, Inc. (Canada)

5.9.2 Gene Vector Product Type, Application and Specification

5.9.2.1 Type I

5.9.2.2 Type II

5.9.3 Gallus Immunotech, Inc. (Canada) Gene Vector Sales, Revenue, Price and Gross Margin (2011-2016)

5.9.4 Main Business/Business Overview

5.10 GE Healthcare (UK)

5.10.2 Gene Vector Product Type, Application and Specification

5.10.2.1 Type I

5.10.2.2 Type II

5.10.3 GE Healthcare (UK) Gene Vector Sales, Revenue, Price and Gross Margin (2011-2016)

5.10.4 Main Business/Business Overview

5.11 Lonza Biologics Ltd. (Switzerland)

5.12 Merck KGaA (Germany)

5.13 Meridian Life Science, Inc. (US)

5.14 PerkinElmer, Inc. (US)

5.15 Promega Corporation (US)

5.16 Qiagen N.V. (Netherlands)

5.17 R&D Systems (US)

5.18 SDIX, LLC (US)

5.19 Shimadzu Corporation (Japan)

5.20 Takara Bio, Inc. (Japan)

5.21 Thermo Fisher Scientific Inc. (US)

5.22 Wako Pure Chemical Industries Ltd. (Japan)

5.23 Waters Corp. (US)

6 Gene Vector Manufacturing Cost Analysis

6.1 Gene Vector Key Raw Materials Analysis

6.1.1 Key Raw Materials

6.1.2 Price Trend of Key Raw Materials

6.1.3 Key Suppliers of Raw Materials

6.1.4 Market Concentration Rate of Raw Materials

6.2 Proportion of Manufacturing Cost Structure

6.2.1 Raw Materials

6.2.2 Labor Cost

6.2.3 Manufacturing Expenses

6.3 Manufacturing Process Analysis of Gene Vector

7 Industrial Chain, Sourcing Strategy and Downstream Buyers

7.1 Gene Vector Industrial Chain Analysis

7.2 Upstream Raw Materials Sourcing

7.3 Raw Materials Sources of Gene Vector Major Manufacturers in 2015

7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders

8.1 Marketing Channel

8.1.1 Direct Marketing

8.1.2 Indirect Marketing

8.1.3 Marketing Channel Development Trend

8.2 Market Positioning

8.2.1 Pricing Strategy

8.2.2 Brand Strategy

8.2.3 Target Client

8.3 Distributors/Traders List

9 Market Effect Factors Analysis

9.1 Technology Progress/Risk

9.1.1 Substitutes Threat

9.1.2 Technology Progress in Related Industry

9.2 Consumer Needs/Customer Preference Change

9.3 Economic/Political Environmental Change

10 USA Gene Vector Market Forecast (2016-2021)

10.1 USA Gene Vector Sales, Revenue Forecast (2016-2021)

10.2 USA Gene Vector Sales Forecast by Type (2016-2021)

10.3 USA Gene Vector Sales Forecast by Application (2016-2021)

10.4 Gene Vector Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

Disclaimer

List of Tables and Figures

Figure Picture of Gene Vector

Table Classification of Gene Vector

Figure USA Sales Market Share of Gene Vector by Type in 2015

Table Application of Gene Vector

Figure USA Sales Market Share of Gene Vector by Application in 2015

Figure Medical care Examples

Figure Experiment Examples

Figure USA Gene Vector Sales and Growth Rate (2011-2021)

Figure USA Gene Vector Revenue and Growth Rate (2011-2021)

Table USA Gene Vector Sales of Key Manufacturers (2015 and 2016)

Table USA Gene Vector Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Gene Vector Sales Share by Manufacturers

Figure 2016 Gene Vector Sales Share by Manufacturers

Table USA Gene Vector Revenue by Manufacturers (2015 and 2016)

Table USA Gene Vector Revenue Share by Manufacturers (2015 and 2016)

Table 2015 USA Gene Vector Revenue Share by Manufacturers

Table 2016 USA Gene Vector Revenue Share by Manufacturers

Table USA Market Gene Vector Average Price of Key Manufacturers (2015 and 2016)

Figure USA Market Gene Vector Average Price of Key Manufacturers in 2015

Figure Gene Vector Market Share of Top 3 Manufacturers

Figure Gene Vector Market Share of Top 5 Manufacturers

Table USA Gene Vector Sales by Type (2011-2016)

Table USA Gene Vector Sales Share by Type (2011-2016)

Figure USA Gene Vector Sales Market Share by Type in 2015

Table USA Gene Vector Revenue and Market Share by Type (2011-2016)

Table USA Gene Vector Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Gene Vector by Type (2011-2016)

Table USA Gene Vector Price by Type (2011-2016)

Figure USA Gene Vector Sales Growth Rate by Type (2011-2016)

Table USA Gene Vector Sales by Application (2011-2016)

Table USA Gene Vector Sales Market Share by Application (2011-2016)

Figure USA Gene Vector Sales Market Share by Application in 2015

Table USA Gene Vector Sales Growth Rate by Application (2011-2016)

Figure USA Gene Vector Sales Growth Rate by Application (2011-2016)

Table A.G. Scientific, Inc. (US) Basic Information List

Table A.G. Scientific, Inc. (US) Gene Vector Sales, Revenue, Price and Gross Margin (2011-2016)

Figure A.G. Scientific, Inc. (US) Gene Vector Sales Market Share (2011-2016)

Table Abbott Diagnostics (US) Basic Information List

Table Abbott Diagnostics (US) Gene Vector Sales, Revenue, Price and Gross Margin (2011-2016)

Table Abbott Diagnostics (US) Gene Vector Sales Market Share (2011-2016)

Table Agilent Technologies, Inc. (US) Basic Information List

Table Agilent Technologies, Inc. (US) Gene Vector Sales, Revenue, Price and Gross Margin (2011-2016)

Table Agilent Technologies, Inc. (US) Gene Vector Sales Market Share (2011-2016)

Table BD Biosciences (US) Basic Information List

Table BD Biosciences (US) Gene Vector Sales, Revenue, Price and Gross Margin (2011-2016)

Table BD Biosciences (US) Gene Vector Sales Market Share (2011-2016)

Table Beckman Coulter, Inc. (US) Basic Information List

Table Beckman Coulter, Inc. (US) Gene Vector Sales, Revenue, Price and Gross Margin (2011-2016)

Table Beckman Coulter, Inc. (US) Gene Vector Sales Market Share (2011-2016)

Table bioMerieux (France) Basic Information List

Table bioMerieux (France) Gene Vector Sales, Revenue, Price and Gross Margin (2011-2016)

Table bioMerieux (France) Gene Vector Sales Market Share (2011-2016)

Table Bio-Rad Laboratories, Inc. (US) Basic Information List

Table Bio-Rad Laboratories, Inc. (US) Gene Vector Sales, Revenue, Price and Gross Margin (2011-2016)

Table Bio-Rad Laboratories, Inc. (US) Gene Vector Sales Market Share (2011-2016)

Table F. Hoffmann-La Roche Ltd. (Switzerland) Basic Information List

Table F. Hoffmann-La Roche Ltd. (Switzerland) Gene Vector Sales, Revenue, Price and Gross Margin (2011-2016)

Table F. Hoffmann-La Roche Ltd. (Switzerland) Gene Vector Sales Market Share (2011-2016)

Table Gallus Immunotech, Inc. (Canada) Basic Information List

Table Gallus Immunotech, Inc. (Canada) Gene Vector Sales, Revenue, Price and Gross Margin (2011-2016)

Table Gallus Immunotech, Inc. (Canada) Gene Vector Sales Market Share (2011-2016)

Table GE Healthcare (UK) Basic Information List

Table GE Healthcare (UK) Gene Vector Sales, Revenue, Price and Gross Margin (2011-2016)

Table GE Healthcare (UK) Gene Vector Sales Market Share (2011-2016)

Table Lonza Biologics Ltd. (Switzerland) Basic Information List

Table Lonza Biologics Ltd. (Switzerland) Gene Vector Sales, Revenue, Price and Gross Margin (2011-2016)

Table Lonza Biologics Ltd. (Switzerland) Gene Vector Sales Market Share (2011-2016)

Table Merck KGaA (Germany) Basic Information List

Table Merck KGaA (Germany) Gene Vector Sales, Revenue, Price and Gross Margin (2011-2016)

Table Merck KGaA (Germany) Gene Vector Sales Market Share (2011-2016)

Table Meridian Life Science, Inc. (US) Basic Information List

Table Meridian Life Science, Inc. (US) Gene Vector Sales, Revenue, Price and Gross Margin (2011-2016)

Table Meridian Life Science, Inc. (US) Gene Vector Sales Market Share (2011-2016)

Table PerkinElmer, Inc. (US) Basic Information List

Table PerkinElmer, Inc. (US) Gene Vector Sales, Revenue, Price and Gross Margin (2011-2016)

Table PerkinElmer, Inc. (US) Gene Vector Sales Market Share (2011-2016)

Table Promega Corporation (US) Basic Information List

Table Promega Corporation (US) Gene Vector Sales, Revenue, Price and Gross Margin (2011-2016)

Table Promega Corporation (US) Gene Vector Sales Market Share (2011-2016)

Table Qiagen N.V. (Netherlands) Basic Information List

Table Qiagen N.V. (Netherlands) Gene Vector Sales, Revenue, Price and Gross Margin (2011-2016)

Table Qiagen N.V. (Netherlands) Gene Vector Sales Market Share (2011-2016)

Table R&D Systems (US) Basic Information List

Table R&D Systems (US) Gene Vector Sales, Revenue, Price and Gross Margin (2011-2016)

Table R&D Systems (US) Gene Vector Sales Market Share (2011-2016)

Table SDIX, LLC (US) Basic Information List

Table SDIX, LLC (US) Gene Vector Sales, Revenue, Price and Gross Margin (2011-2016)

Table SDIX, LLC (US) Gene Vector Sales Market Share (2011-2016)

Table Shimadzu Corporation (Japan) Basic Information List

Table Shimadzu Corporation (Japan) Gene Vector Sales, Revenue, Price and Gross Margin (2011-2016)

Table Shimadzu Corporation (Japan) Gene Vector Sales Market Share (2011-2016)

Table Takara Bio, Inc. (Japan) Basic Information List

Table Takara Bio, Inc. (Japan) Gene Vector Sales, Revenue, Price and Gross Margin (2011-2016)

Table Takara Bio, Inc. (Japan) Gene Vector Sales Market Share (2011-2016)

Table Thermo Fisher Scientific Inc. (US) Basic Information List

Table Thermo Fisher Scientific Inc. (US) Gene Vector Sales, Revenue, Price and Gross Margin (2011-2016)

Table Thermo Fisher Scientific Inc. (US) Gene Vector Sales Market Share (2011-2016)

Table Wako Pure Chemical Industries Ltd. (Japan) Basic Information List

Table Wako Pure Chemical Industries Ltd. (Japan) Gene Vector Sales, Revenue, Price and Gross Margin (2011-2016)

Table Wako Pure Chemical Industries Ltd. (Japan) Gene Vector Sales Market Share (2011-2016)

Table Waters Corp. (US) Basic Information List

Table Waters Corp. (US) Gene Vector Sales, Revenue, Price and Gross Margin (2011-2016)

Table Waters Corp. (US) Gene Vector Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Gene Vector

Figure Manufacturing Process Analysis of Gene Vector

Figure Gene Vector Industrial Chain Analysis

Table Raw Materials Sources of Gene Vector Major Manufacturers in 2015

Table Major Buyers of Gene Vector

Table Distributors/Traders List

Figure USA Gene Vector Production and Growth Rate Forecast (2016-2021)

Figure USA Gene Vector Revenue and Growth Rate Forecast (2016-2021)

Table USA Gene Vector Production Forecast by Type (2016-2021)

Table USA Gene Vector Consumption Forecast by Application (2016-2021)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390